Please note that some translations using Google Translate may not be accurately represented and downloaded documents cannot be translated. Dana-Farber and the Jimmy Fund assume no liability for inaccuracies that may result from using this third-party tool, which is for website translation.
Stand Up To Cancer features Count Me In
Now more than ever, it’s critical for researchers to unlock new information about cancer. When patients and researchers come together to share personal data and experiences, they can uncover new discoveries, solutions, and treatments for numerous types of cancer. This is the guiding mission of Count Me In, a partnership between Dana-Farber Cancer Institute, the Broad Institute, and Emerson Collective.
As featured on the seventh biennial Stand Up To Cancer (SU2C) broadcast event on August 21, 2021, to support critically needed funding for cancer research and treatment, Count Me In is spearheading the effort to accelerate groundbreaking cancer research and defy cancer through direct collaboration with patients.
Nikhil Wagle, MD, director of Count Me In and a medical oncologist and cancer researcher at Dana-Farber and the Broad Institute, leads this initiative to help ensure that every patient’s experience with cancer is counted, no matter where in the U.S. or Canada they live.
Wagle and his team encourage patients to join Count Me In and share their experiences with cancer, their medical information, and even their cancer samples. Patients’ medical records, tumor samples, and personal experiences hold clues—about which cancers will respond or become resistant to which therapies—that often can’t be found in research labs or clinical trials. Count Me In enables cancer patients anywhere to share their information with researchers everywhere.
If you’ve been diagnosed with cancer and would like to become part of the movement to accelerate cancer research, learn more about Count Me In and how your data and experience can help uncover the next medical breakthrough.
Support efforts like these by joining The Dana-Farber Campaign, our ambitious, multi-year fundraising effort to prevent, treat, and defy cancer. The Dana-Farber Campaign will accelerate the Institute’s strategic priorities by supporting revolutionary science, extraordinary care, and exceptional expertise. As a community, we have the power to create a more hopeful, cancer-free future—in Boston and around the world. Together, we can defy cancer at every turn. Learn more about The Dana-Farber Campaign at DefyCancer.org.
